Global Medical Antifungal Agent Supply, Demand and Key Producers, 2023-2029
Page: 118
Published Date: 05 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Medical Antifungal Agent market size is expected to reach $ 16240 million by 2029, rising at a market growth of 2.8% CAGR during the forecast period (2023-2029).
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Antifungals are medicines that kill or stop the growth of fungi that cause infections.
This report studies the global Medical Antifungal Agent production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Antifungal Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Antifungal Agent that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Antifungal Agent total production and demand, 2018-2029, (K Units)
Global Medical Antifungal Agent total production value, 2018-2029, (USD Million)
Global Medical Antifungal Agent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Antifungal Agent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Medical Antifungal Agent domestic production, consumption, key domestic manufacturers and share
Global Medical Antifungal Agent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Medical Antifungal Agent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Antifungal Agent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Medical Antifungal Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Pfizer, Bayer, Sanofi, Merck & Co, GlaxoSmithKline, MSD Manuals, Abbott and Glenmark, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Antifungal Agent market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Medical Antifungal Agent Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Medical Antifungal Agent Market, Segmentation by Type
Azoles
Echinocandins
Polyenes
Allylamines
Others
Global Medical Antifungal Agent Market, Segmentation by Application
Dermatophytosis
Aspergillosis
Candidiasis
Others
Companies Profiled:
Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
Key Questions Answered
1. How big is the global Medical Antifungal Agent market?
2. What is the demand of the global Medical Antifungal Agent market?
3. What is the year over year growth of the global Medical Antifungal Agent market?
4. What is the production and production value of the global Medical Antifungal Agent market?
5. Who are the key producers in the global Medical Antifungal Agent market?
Table of Contents
1 Supply Summary
1.1 Medical Antifungal Agent Introduction
1.2 World Medical Antifungal Agent Supply & Forecast
1.2.1 World Medical Antifungal Agent Production Value (2018 & 2022 & 2029)
1.2.2 World Medical Antifungal Agent Production (2018-2029)
1.2.3 World Medical Antifungal Agent Pricing Trends (2018-2029)
1.3 World Medical Antifungal Agent Production by Region (Based on Production Site)
1.3.1 World Medical Antifungal Agent Production Value by Region (2018-2029)
1.3.2 World Medical Antifungal Agent Production by Region (2018-2029)
1.3.3 World Medical Antifungal Agent Average Price by Region (2018-2029)
1.3.4 North America Medical Antifungal Agent Production (2018-2029)
1.3.5 Europe Medical Antifungal Agent Production (2018-2029)
1.3.6 China Medical Antifungal Agent Production (2018-2029)
1.3.7 Japan Medical Antifungal Agent Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Antifungal Agent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Antifungal Agent Major Market Trends
2 Demand Summary
2.1 World Medical Antifungal Agent Demand (2018-2029)
2.2 World Medical Antifungal Agent Consumption by Region
2.2.1 World Medical Antifungal Agent Consumption by Region (2018-2023)
2.2.2 World Medical Antifungal Agent Consumption Forecast by Region (2024-2029)
2.3 United States Medical Antifungal Agent Consumption (2018-2029)
2.4 China Medical Antifungal Agent Consumption (2018-2029)
2.5 Europe Medical Antifungal Agent Consumption (2018-2029)
2.6 Japan Medical Antifungal Agent Consumption (2018-2029)
2.7 South Korea Medical Antifungal Agent Consumption (2018-2029)
2.8 ASEAN Medical Antifungal Agent Consumption (2018-2029)
2.9 India Medical Antifungal Agent Consumption (2018-2029)
3 World Medical Antifungal Agent Manufacturers Competitive Analysis
3.1 World Medical Antifungal Agent Production Value by Manufacturer (2018-2023)
3.2 World Medical Antifungal Agent Production by Manufacturer (2018-2023)
3.3 World Medical Antifungal Agent Average Price by Manufacturer (2018-2023)
3.4 Medical Antifungal Agent Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medical Antifungal Agent Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medical Antifungal Agent in 2022
3.5.3 Global Concentration Ratios (CR8) for Medical Antifungal Agent in 2022
3.6 Medical Antifungal Agent Market: Overall Company Footprint Analysis
3.6.1 Medical Antifungal Agent Market: Region Footprint
3.6.2 Medical Antifungal Agent Market: Company Product Type Footprint
3.6.3 Medical Antifungal Agent Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Medical Antifungal Agent Production Value Comparison
4.1.1 United States VS China: Medical Antifungal Agent Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Medical Antifungal Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Medical Antifungal Agent Production Comparison
4.2.1 United States VS China: Medical Antifungal Agent Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medical Antifungal Agent Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Medical Antifungal Agent Consumption Comparison
4.3.1 United States VS China: Medical Antifungal Agent Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Medical Antifungal Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Medical Antifungal Agent Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medical Antifungal Agent Production Value (2018-2023)
4.4.3 United States Based Manufacturers Medical Antifungal Agent Production (2018-2023)
4.5 China Based Medical Antifungal Agent Manufacturers and Market Share
4.5.1 China Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medical Antifungal Agent Production Value (2018-2023)
4.5.3 China Based Manufacturers Medical Antifungal Agent Production (2018-2023)
4.6 Rest of World Based Medical Antifungal Agent Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medical Antifungal Agent Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Medical Antifungal Agent Production (2018-2023)
5 Market Analysis by Type
5.1 World Medical Antifungal Agent Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Azoles
5.2.2 Echinocandins
5.2.3 Polyenes
5.2.4 Allylamines
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Medical Antifungal Agent Production by Type (2018-2029)
5.3.2 World Medical Antifungal Agent Production Value by Type (2018-2029)
5.3.3 World Medical Antifungal Agent Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Medical Antifungal Agent Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Dermatophytosis
6.2.2 Aspergillosis
6.2.3 Candidiasis
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Medical Antifungal Agent Production by Application (2018-2029)
6.3.2 World Medical Antifungal Agent Production Value by Application (2018-2029)
6.3.3 World Medical Antifungal Agent Average Price by Application (2018-2029)
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Medical Antifungal Agent Product and Services
7.1.4 Novartis Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Medical Antifungal Agent Product and Services
7.2.4 Pfizer Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Medical Antifungal Agent Product and Services
7.3.4 Bayer Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Medical Antifungal Agent Product and Services
7.4.4 Sanofi Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Merck & Co
7.5.1 Merck & Co Details
7.5.2 Merck & Co Major Business
7.5.3 Merck & Co Medical Antifungal Agent Product and Services
7.5.4 Merck & Co Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Merck & Co Recent Developments/Updates
7.5.6 Merck & Co Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Details
7.6.2 GlaxoSmithKline Major Business
7.6.3 GlaxoSmithKline Medical Antifungal Agent Product and Services
7.6.4 GlaxoSmithKline Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GlaxoSmithKline Recent Developments/Updates
7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.7 MSD Manuals
7.7.1 MSD Manuals Details
7.7.2 MSD Manuals Major Business
7.7.3 MSD Manuals Medical Antifungal Agent Product and Services
7.7.4 MSD Manuals Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MSD Manuals Recent Developments/Updates
7.7.6 MSD Manuals Competitive Strengths & Weaknesses
7.8 Abbott
7.8.1 Abbott Details
7.8.2 Abbott Major Business
7.8.3 Abbott Medical Antifungal Agent Product and Services
7.8.4 Abbott Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Abbott Recent Developments/Updates
7.8.6 Abbott Competitive Strengths & Weaknesses
7.9 Glenmark
7.9.1 Glenmark Details
7.9.2 Glenmark Major Business
7.9.3 Glenmark Medical Antifungal Agent Product and Services
7.9.4 Glenmark Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Glenmark Recent Developments/Updates
7.9.6 Glenmark Competitive Strengths & Weaknesses
7.10 Enzon Pharmaceuticals
7.10.1 Enzon Pharmaceuticals Details
7.10.2 Enzon Pharmaceuticals Major Business
7.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
7.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Enzon Pharmaceuticals Recent Developments/Updates
7.10.6 Enzon Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Astellas Pharma
7.11.1 Astellas Pharma Details
7.11.2 Astellas Pharma Major Business
7.11.3 Astellas Pharma Medical Antifungal Agent Product and Services
7.11.4 Astellas Pharma Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Astellas Pharma Recent Developments/Updates
7.11.6 Astellas Pharma Competitive Strengths & Weaknesses
7.12 Scynexis
7.12.1 Scynexis Details
7.12.2 Scynexis Major Business
7.12.3 Scynexis Medical Antifungal Agent Product and Services
7.12.4 Scynexis Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Scynexis Recent Developments/Updates
7.12.6 Scynexis Competitive Strengths & Weaknesses
7.13 Cidara Therapeutics
7.13.1 Cidara Therapeutics Details
7.13.2 Cidara Therapeutics Major Business
7.13.3 Cidara Therapeutics Medical Antifungal Agent Product and Services
7.13.4 Cidara Therapeutics Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Cidara Therapeutics Recent Developments/Updates
7.13.6 Cidara Therapeutics Competitive Strengths & Weaknesses
7.14 Lucigen Corporation
7.14.1 Lucigen Corporation Details
7.14.2 Lucigen Corporation Major Business
7.14.3 Lucigen Corporation Medical Antifungal Agent Product and Services
7.14.4 Lucigen Corporation Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Lucigen Corporation Recent Developments/Updates
7.14.6 Lucigen Corporation Competitive Strengths & Weaknesses
7.15 Biosergen
7.15.1 Biosergen Details
7.15.2 Biosergen Major Business
7.15.3 Biosergen Medical Antifungal Agent Product and Services
7.15.4 Biosergen Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Biosergen Recent Developments/Updates
7.15.6 Biosergen Competitive Strengths & Weaknesses
7.16 F2G
7.16.1 F2G Details
7.16.2 F2G Major Business
7.16.3 F2G Medical Antifungal Agent Product and Services
7.16.4 F2G Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 F2G Recent Developments/Updates
7.16.6 F2G Competitive Strengths & Weaknesses
7.17 Sichuan Meidakang Pharmaceutical
7.17.1 Sichuan Meidakang Pharmaceutical Details
7.17.2 Sichuan Meidakang Pharmaceutical Major Business
7.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
7.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Sichuan Meidakang Pharmaceutical Recent Developments/Updates
7.17.6 Sichuan Meidakang Pharmaceutical Competitive Strengths & Weaknesses
7.18 Chengdu Taihe Health Technology
7.18.1 Chengdu Taihe Health Technology Details
7.18.2 Chengdu Taihe Health Technology Major Business
7.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
7.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Chengdu Taihe Health Technology Recent Developments/Updates
7.18.6 Chengdu Taihe Health Technology Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Medical Antifungal Agent Industry Chain
8.2 Medical Antifungal Agent Upstream Analysis
8.2.1 Medical Antifungal Agent Core Raw Materials
8.2.2 Main Manufacturers of Medical Antifungal Agent Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medical Antifungal Agent Production Mode
8.6 Medical Antifungal Agent Procurement Model
8.7 Medical Antifungal Agent Industry Sales Model and Sales Channels
8.7.1 Medical Antifungal Agent Sales Model
8.7.2 Medical Antifungal Agent Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Medical Antifungal Agent Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Medical Antifungal Agent Production Value by Region (2018-2023) & (USD Million)
Table 3. World Medical Antifungal Agent Production Value by Region (2024-2029) & (USD Million)
Table 4. World Medical Antifungal Agent Production Value Market Share by Region (2018-2023)
Table 5. World Medical Antifungal Agent Production Value Market Share by Region (2024-2029)
Table 6. World Medical Antifungal Agent Production by Region (2018-2023) & (K Units)
Table 7. World Medical Antifungal Agent Production by Region (2024-2029) & (K Units)
Table 8. World Medical Antifungal Agent Production Market Share by Region (2018-2023)
Table 9. World Medical Antifungal Agent Production Market Share by Region (2024-2029)
Table 10. World Medical Antifungal Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Medical Antifungal Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Medical Antifungal Agent Major Market Trends
Table 13. World Medical Antifungal Agent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Medical Antifungal Agent Consumption by Region (2018-2023) & (K Units)
Table 15. World Medical Antifungal Agent Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Medical Antifungal Agent Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Medical Antifungal Agent Producers in 2022
Table 18. World Medical Antifungal Agent Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Medical Antifungal Agent Producers in 2022
Table 20. World Medical Antifungal Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Medical Antifungal Agent Company Evaluation Quadrant
Table 22. World Medical Antifungal Agent Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Medical Antifungal Agent Production Site of Key Manufacturer
Table 24. Medical Antifungal Agent Market: Company Product Type Footprint
Table 25. Medical Antifungal Agent Market: Company Product Application Footprint
Table 26. Medical Antifungal Agent Competitive Factors
Table 27. Medical Antifungal Agent New Entrant and Capacity Expansion Plans
Table 28. Medical Antifungal Agent Mergers & Acquisitions Activity
Table 29. United States VS China Medical Antifungal Agent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Medical Antifungal Agent Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Medical Antifungal Agent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medical Antifungal Agent Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Medical Antifungal Agent Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Medical Antifungal Agent Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Medical Antifungal Agent Production Market Share (2018-2023)
Table 37. China Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medical Antifungal Agent Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Medical Antifungal Agent Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Medical Antifungal Agent Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Medical Antifungal Agent Production Market Share (2018-2023)
Table 42. Rest of World Based Medical Antifungal Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Medical Antifungal Agent Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Medical Antifungal Agent Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Medical Antifungal Agent Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Medical Antifungal Agent Production Market Share (2018-2023)
Table 47. World Medical Antifungal Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Medical Antifungal Agent Production by Type (2018-2023) & (K Units)
Table 49. World Medical Antifungal Agent Production by Type (2024-2029) & (K Units)
Table 50. World Medical Antifungal Agent Production Value by Type (2018-2023) & (USD Million)
Table 51. World Medical Antifungal Agent Production Value by Type (2024-2029) & (USD Million)
Table 52. World Medical Antifungal Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Medical Antifungal Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Medical Antifungal Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Medical Antifungal Agent Production by Application (2018-2023) & (K Units)
Table 56. World Medical Antifungal Agent Production by Application (2024-2029) & (K Units)
Table 57. World Medical Antifungal Agent Production Value by Application (2018-2023) & (USD Million)
Table 58. World Medical Antifungal Agent Production Value by Application (2024-2029) & (USD Million)
Table 59. World Medical Antifungal Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Medical Antifungal Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Medical Antifungal Agent Product and Services
Table 64. Novartis Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Medical Antifungal Agent Product and Services
Table 70. Pfizer Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Medical Antifungal Agent Product and Services
Table 76. Bayer Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Medical Antifungal Agent Product and Services
Table 82. Sanofi Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 86. Merck & Co Major Business
Table 87. Merck & Co Medical Antifungal Agent Product and Services
Table 88. Merck & Co Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Merck & Co Recent Developments/Updates
Table 90. Merck & Co Competitive Strengths & Weaknesses
Table 91. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 92. GlaxoSmithKline Major Business
Table 93. GlaxoSmithKline Medical Antifungal Agent Product and Services
Table 94. GlaxoSmithKline Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GlaxoSmithKline Recent Developments/Updates
Table 96. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 97. MSD Manuals Basic Information, Manufacturing Base and Competitors
Table 98. MSD Manuals Major Business
Table 99. MSD Manuals Medical Antifungal Agent Product and Services
Table 100. MSD Manuals Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MSD Manuals Recent Developments/Updates
Table 102. MSD Manuals Competitive Strengths & Weaknesses
Table 103. Abbott Basic Information, Manufacturing Base and Competitors
Table 104. Abbott Major Business
Table 105. Abbott Medical Antifungal Agent Product and Services
Table 106. Abbott Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Abbott Recent Developments/Updates
Table 108. Abbott Competitive Strengths & Weaknesses
Table 109. Glenmark Basic Information, Manufacturing Base and Competitors
Table 110. Glenmark Major Business
Table 111. Glenmark Medical Antifungal Agent Product and Services
Table 112. Glenmark Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Glenmark Recent Developments/Updates
Table 114. Glenmark Competitive Strengths & Weaknesses
Table 115. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Enzon Pharmaceuticals Major Business
Table 117. Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
Table 118. Enzon Pharmaceuticals Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Enzon Pharmaceuticals Recent Developments/Updates
Table 120. Enzon Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Astellas Pharma Major Business
Table 123. Astellas Pharma Medical Antifungal Agent Product and Services
Table 124. Astellas Pharma Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Astellas Pharma Recent Developments/Updates
Table 126. Astellas Pharma Competitive Strengths & Weaknesses
Table 127. Scynexis Basic Information, Manufacturing Base and Competitors
Table 128. Scynexis Major Business
Table 129. Scynexis Medical Antifungal Agent Product and Services
Table 130. Scynexis Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Scynexis Recent Developments/Updates
Table 132. Scynexis Competitive Strengths & Weaknesses
Table 133. Cidara Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Cidara Therapeutics Major Business
Table 135. Cidara Therapeutics Medical Antifungal Agent Product and Services
Table 136. Cidara Therapeutics Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Cidara Therapeutics Recent Developments/Updates
Table 138. Cidara Therapeutics Competitive Strengths & Weaknesses
Table 139. Lucigen Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Lucigen Corporation Major Business
Table 141. Lucigen Corporation Medical Antifungal Agent Product and Services
Table 142. Lucigen Corporation Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Lucigen Corporation Recent Developments/Updates
Table 144. Lucigen Corporation Competitive Strengths & Weaknesses
Table 145. Biosergen Basic Information, Manufacturing Base and Competitors
Table 146. Biosergen Major Business
Table 147. Biosergen Medical Antifungal Agent Product and Services
Table 148. Biosergen Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Biosergen Recent Developments/Updates
Table 150. Biosergen Competitive Strengths & Weaknesses
Table 151. F2G Basic Information, Manufacturing Base and Competitors
Table 152. F2G Major Business
Table 153. F2G Medical Antifungal Agent Product and Services
Table 154. F2G Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. F2G Recent Developments/Updates
Table 156. F2G Competitive Strengths & Weaknesses
Table 157. Sichuan Meidakang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 158. Sichuan Meidakang Pharmaceutical Major Business
Table 159. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
Table 160. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Sichuan Meidakang Pharmaceutical Recent Developments/Updates
Table 162. Chengdu Taihe Health Technology Basic Information, Manufacturing Base and Competitors
Table 163. Chengdu Taihe Health Technology Major Business
Table 164. Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
Table 165. Chengdu Taihe Health Technology Medical Antifungal Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Medical Antifungal Agent Upstream (Raw Materials)
Table 167. Medical Antifungal Agent Typical Customers
Table 168. Medical Antifungal Agent Typical Distributors
List of Figure
Figure 1. Medical Antifungal Agent Picture
Figure 2. World Medical Antifungal Agent Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medical Antifungal Agent Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Medical Antifungal Agent Production (2018-2029) & (K Units)
Figure 5. World Medical Antifungal Agent Average Price (2018-2029) & (US$/Unit)
Figure 6. World Medical Antifungal Agent Production Value Market Share by Region (2018-2029)
Figure 7. World Medical Antifungal Agent Production Market Share by Region (2018-2029)
Figure 8. North America Medical Antifungal Agent Production (2018-2029) & (K Units)
Figure 9. Europe Medical Antifungal Agent Production (2018-2029) & (K Units)
Figure 10. China Medical Antifungal Agent Production (2018-2029) & (K Units)
Figure 11. Japan Medical Antifungal Agent Production (2018-2029) & (K Units)
Figure 12. Medical Antifungal Agent Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 15. World Medical Antifungal Agent Consumption Market Share by Region (2018-2029)
Figure 16. United States Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 17. China Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 18. Europe Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 19. Japan Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 20. South Korea Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 22. India Medical Antifungal Agent Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Medical Antifungal Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Medical Antifungal Agent Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Medical Antifungal Agent Markets in 2022
Figure 26. United States VS China: Medical Antifungal Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Medical Antifungal Agent Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medical Antifungal Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Medical Antifungal Agent Production Market Share 2022
Figure 30. China Based Manufacturers Medical Antifungal Agent Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Medical Antifungal Agent Production Market Share 2022
Figure 32. World Medical Antifungal Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Medical Antifungal Agent Production Value Market Share by Type in 2022
Figure 34. Azoles
Figure 35. Echinocandins
Figure 36. Polyenes
Figure 37. Allylamines
Figure 38. Others
Figure 39. World Medical Antifungal Agent Production Market Share by Type (2018-2029)
Figure 40. World Medical Antifungal Agent Production Value Market Share by Type (2018-2029)
Figure 41. World Medical Antifungal Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Medical Antifungal Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Medical Antifungal Agent Production Value Market Share by Application in 2022
Figure 44. Dermatophytosis
Figure 45. Aspergillosis
Figure 46. Candidiasis
Figure 47. Others
Figure 48. World Medical Antifungal Agent Production Market Share by Application (2018-2029)
Figure 49. World Medical Antifungal Agent Production Value Market Share by Application (2018-2029)
Figure 50. World Medical Antifungal Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Medical Antifungal Agent Industry Chain
Figure 52. Medical Antifungal Agent Procurement Model
Figure 53. Medical Antifungal Agent Sales Model
Figure 54. Medical Antifungal Agent Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis Pfizer Bayer Sanofi Merck & Co GlaxoSmithKline MSD Manuals Abbott Glenmark Enzon Pharmaceuticals Astellas Pharma Scynexis Cidara Therapeutics Lucigen Corporation Biosergen F2G Sichuan Meidakang Pharmaceutical Chengdu Taihe Health Technology
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>